Wendell Amy McBride 4

What Happened

Wendell Amy McBride, a director of Axogen, exercised 1,647 stock options (exercise price $14.85) on May 8, 2026, incurring an exercise cost of $24,458. The same day the 1,647 shares were sold in the open market for total gross proceeds of $70,162 at a weighted average sale price of $42.60. Net proceeds before taxes and fees were roughly $45,704.

Key Details

• Transaction date: May 8, 2026.
• Option exercise: 1,647 shares @ $14.85 per share = $24,458 (acquired).
• Sale: 1,647 shares sold @ weighted avg $42.60 per share = $70,162 (disposed). Sale prices ranged from $42.50 to $42.62 (see footnote F1).
• Derivative entry: filing shows the derivative underlying the options was converted/disposed (recorded at $0.00) as part of the transaction.
• Vesting: the options were fully vested as of May 31, 2018 (footnote F2).
• Shares owned after transaction: not specified in the filing.
• Filing timing: Report filed May 12, 2026 for a May 8 transaction — this appears to be more than two business days after the trade (Form 4s are normally due within two business days).

Context

This was an option exercise followed by an immediate sale (a cashless exercise pattern): the insider converted vested options into shares and sold them the same day. Such transactions are common for exercising long‑held options and do not by themselves indicate future company performance.